home   /   news   /  CCTV Outlook Channel Films a Documentary for Zhejiang Orient Gene Biotech Co., LTD
return
CCTV Outlook Channel Films a Documentary for Zhejiang Orient Gene Biotech Co., LTD
2020-09-15

The documentary program of China Central Radio and TV Station, " Craftsmanship and Wisdom", is a large-scale documentary that records the craftsmanship of enterprises of staying true to the original intention, inheriting and carrying forward, and keep refining, and shows a panoramic view of enterprises creating excellent products. It focuses on the development process of Chinese private enterprises of "Concentrated Creation, Intelligent Craftsmanship", and records the excellent enterprise and entrepreneur groups as well as their marks and stories of "craftsmanship" and "intelligent manufacturing" in the tide of the times.  


Craftsmanship is the pursuit of product excellence; and intelligent manufacturing is the driving force to advance the world. Through the creation of excellent products, private enterprises in China are fulfilling their responsibility to the country by focusing on "craftsmanship", providing a strong support for the "National Brand" and "Made in China"; and through the provision of quality services, private enterprises in China are assuming responsibility for the public by pursuing the advantages of "intelligent manufacturing".


The Craftsmanship and Wisdom documentary series aim to make the world feel the unique charm of and fall in love with Made in China.


In early September 2020, a team from the "Craftsmanship and Wisdom" program visited Anji, Zhejiang Province, the place where the concept of "lucid waters and lush mountains are invaluable assets " was first initiated, to record the green waters and mountains here. Meanwhile, the film crew were deeply moved by a local medical device company, Zhejiang Orient Gene Biotech Co., LTD (stock code 688298), which was listed on the SSE STAR market in February this year, as well as its "craftsmanship" and dedication in supporting the global efforts in the prevention and control of COVID-19 epidemic in the first half of the year. 


图片1.png


Zhejiang Orient Gene Biotech Co., LTD is a Chinese company excelling in the global fight against the ravaging epidemic in 2020. With all the curiousness about the company, we went on a field trip to Anji, the headquarters of Zhejiang Orient Gene Biotech Co., LTD. 


图片2.png


Mr. Fang Xiaoliang, President of Zhejiang Orient Gene Biotech Co., LTD, and other executives personally received the guests. Mr. Fang introduced the development course of the Company with exciting entrepreneurship stories. Meanwhile, through the visit to the exhibition hall and production workshop, the film crew had an in-depth understanding of the quality requirements of the international market as well as the wisdom of craftsmanship, quality values and the attitude towards Made in China of the Company. During the visit, both sides had an in-depth discussion on the topics of concerns with a relaxed and warm atmosphere. 


未标题-1.jpg


We learned that Zhejiang Orient Gene Biotech Co., LTD, founded in December 2005, has an entrepreneurship and development history of 15 years, and was listed on the SSE STAR Market on February 5, 2020. It is a company specializing in the development, production and sales of in vitro diagnostic products and is engaged in the field of high-end medical equipment and devices.


Presently, the Company mainly focuses on POCT instant diagnostic reagents, which are applied in fields such as infectious disease detection (including COVID-19 detection series), drug detection, eugenics detection, tumor marker detection and myocardial marker detection. The Company has completed the strategic layout of the whole industrial chain from biological raw materials such as antigens and antibodies to in-vitro diagnostic reagents and in-vitro diagnostic instruments, with its leading technology in the industry.


Especially, facing the raging epidemic of COVID-19, the Company has successfully developed three COVID-19 detection product series including antibody test strips, nucleic acid test reagents and antigen test strips as early as in the end of January 2020, and applied for EU CE certification for all of these products in February. It is the earliest and most comprehensive COVID-19 detection reagent manufacturer in China, which is sufficient to demonstrate the R&D strength of the Company. Among the products, the COVID-19 antibody detection reagent was authorized for emergency use by the U.S. FDA-EUA in May (the second manufacturer in China) and has the greatest production capacity and export volume in China. The domestic registration certificate was obtained in May for the COVID-19 nucleic acid detection products, which adopts one-step extraction-free process and has better cost performance and detection efficiency than similar products. The COVID-19 antigen test product is the earliest product developed in China as well as the earliest product applied for and obtaining EU CE certification in China (applied in February and certified in April). Up to now, only two companies in China have developed such products, which may gradually replace nucleic acid detection products in the future.  Antigen testing products are now being promoted and used on a large scale in the United States, and the Company will also focus on marketization in the second half of the year. Meanwhile working diligently on product development, quick improvement of production capacity, and assistance to the global fight against the COVID-19 epidemic, the Company also achieved substantial growth in operating performance as well as a major breakthrough in development scale in the first half of the year. 


图片4.png


The Company has obtained about 450 domestic and international medical device certifications, and is one of the Chinese in vitro diagnostics companies with the most international certifications (369), including 35 US FDA (510K) product certifications, 259 EU CE product certifications, 71 Canadian MDL product certifications, 4 Mexican medical device certifications. The Company has been implementing the quality management requirements of developed countries in Europe and the United States, the products are exported to more than 100 countries and regions in America, Europe, Southeast Asia, the Middle East, South Africa, etc., and are widely recognized by developed countries in Europe, the United States, etc.\


Relying on the global R&D team, Zhejiang Orient Gene Biotech Co., LTD has established the "In Vitro Diagnostic Reagents Provincial High-tech Enterprise Research and Development Center" and "Academician Expert Workstation".  The Company has cooperated extensively with Bill & Melinda Gates Foundation, Zhejiang University, Zhejiang Disease Control, Hangzhou Medical College and other domestic and foreign institutions. Multiple products have been awarded a number of honors, such as the National Torch Plan Industrialization Demonstration Project, Zhejiang Province Key High-tech Product and Zhejiang Provincial Science and Technology Achievement.


To understand Zhejiang Orient Gene Biotech Co., LTD in a more comprehensive and intuitive manner, the film crew visited the workshops of the Company and made full communication on the concerned issues. 


图片5-1.png图片5-2.png


After the workshop visit, Mr. Fang continued to introduce the development history and the inspiring craftsmanship of Zhejiang Orient Gene Biotech Co., LTD. Especially in the first half of 2020, with the raging of the new coronary epidemic, countless lives have been painfully lost. Had there been no epidemic, Zhejiang Orient Gene Biotech Co., LTD should have rang the bell on February to celebrate the listing, and unfortunately it was canceled.  Though the listing bell was cancelled, the Company immediately has shouldered the full responsibility as a listed company since then. Under the leadership of the Chairman of the Company and the concerted efforts of all staff, the Company developed COVID-19 detection series of products without delay. Meanwhile, the Company spared no efforts to overcome the difficulties in resuming the production interrupted by COVID-19 and achieved rapid improvement of production capacity in the short term. With maximum efforts to assist in the global prevention and control of the epidemic, the COVID-19 detection products have actually been exported to more than 60 countries. Within half a year after listing, the Company has achieved remarkable operating results with rapid improvement of the development scale. From a company with the smallest market value to a company with relatively large size, the enterprise values are well established.


Finally, the film crew of Craftsmanship and Wisdom conducted substantial examination of the “soft power” of Zhejiang Orient Gene Biotech Co., LTD. After the preliminary, further and final examination, the Company was successfully selected for the documentary program “Craftsmanship and Wisdom” of China Central Radio and Television, and a signing ceremony was held on the spot.